A recent study has shown that adiponectin levels serve as a powerful risk marker for prediabetes in healthy black and white adults with a family history of type 2 diabetes. This research was conducted at the University of Tennessee Health Science Center who studied 182 black and 151 white adults. The goal was to assess their adiponectin baseline levels and compare them to prediabtes incidents.
The study showed that a 1-standard deviation higher baseline level of adiponectin was tied to a 40% lower rate of prediabetes progression. These findings predict that interventions that can increase adiponectin levels could protect against the risk of dysglycemia.
These findings were published in BMJ Open Diabetes Research & Care on March 10, 2016.